AI assistant
FIBROGEN INC — Director's Dealing 2015
Nov 25, 2015
34576_dirs_2015-11-25_211302ad-994b-4897-81ba-6f27ce8d738a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2015-11-23
Reporting Person: KEARNS THOMAS F JR (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-23 | Common Stock | S | 3900 | $28.02 | Disposed | 173836 | Direct |
| 2015-11-24 | Common Stock | S | 1000 | $28.46 | Disposed | 172836 | Direct |
| 2015-11-24 | Common Stock | S | 2900 | $29.19 | Disposed | 169936 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 110000 | Indirect |
Footnotes
F1: Shares sold pursuant to a 10b5-1 plan.
F2: The shares were sold at prices ranging from $27.49 to $28.45. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: The shares were sold at prices ranging from $28.07 to $28.70. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4: The shares were sold at prices ranging from $29.00 to $29.62. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.